[Pancreatic cancer screening: mission impossible?].
Bartel
M
M
Abteilung für Allgemein-, Viszeral- und Unfallchirurgie, Universitätsklinikum Heidelberg. Helmut_Friess@med.uni-heidelberg.de
Friess
H
H
D000230:Adenocarcinoma / Q000097:blood* / Q000601:surgery; D000368:Aged; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D016022:Case-Control Studies; D016207:Cytokines / Q000097:blood*; D005260:Female; D006801:Humans; D037181:Lectins, C-Type / Q000097:blood; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000601:surgery
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D016207:Cytokines; D037181:Lectins, C-Type